Envestnet Asset Management Inc. Purchases 4,971 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Envestnet Asset Management Inc. raised its stake in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 9.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,475 shares of the business services provider's stock after acquiring an additional 4,971 shares during the period. Envestnet Asset Management Inc. owned approximately 0.34% of Huron Consulting Group worth $7,390,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of HURN. Allspring Global Investments Holdings LLC raised its stake in Huron Consulting Group by 61.3% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,972 shares of the business services provider's stock valued at $1,488,000 after purchasing an additional 4,550 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Huron Consulting Group by 20.5% during the 3rd quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider's stock worth $42,306,000 after acquiring an additional 67,239 shares during the period. Aigen Investment Management LP acquired a new stake in shares of Huron Consulting Group during the 4th quarter worth approximately $211,000. Congress Asset Management Co. increased its stake in Huron Consulting Group by 9.0% in the fourth quarter. Congress Asset Management Co. now owns 79,095 shares of the business services provider's stock valued at $9,828,000 after acquiring an additional 6,521 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in Huron Consulting Group by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 101,041 shares of the business services provider's stock valued at $12,555,000 after purchasing an additional 23,059 shares in the last quarter. 93.90% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HURN has been the topic of several recent analyst reports. William Blair reiterated an "outperform" rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Truist Financial lifted their target price on Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a research report on Tuesday, March 4th. Benchmark reissued a "buy" rating and issued a $165.00 target price on shares of Huron Consulting Group in a report on Wednesday, March 26th. Wedbush raised their price target on shares of Huron Consulting Group from $150.00 to $165.00 and gave the company an "outperform" rating in a research note on Wednesday, March 26th. Finally, Barrington Research reiterated an "outperform" rating and set a $167.00 price objective on shares of Huron Consulting Group in a research report on Thursday, March 27th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $169.25.

Insider Buying and Selling

In other news, Director H Eugene Lockhart sold 1,042 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $125.15, for a total transaction of $130,406.30. Following the completion of the transaction, the director now directly owns 24,672 shares in the company, valued at $3,087,700.80. This trade represents a 4.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John Mccartney sold 500 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $151.13, for a total value of $75,565.00. Following the completion of the sale, the director now owns 55,688 shares in the company, valued at $8,416,127.44. The trade was a 0.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 78,781 shares of company stock valued at $11,484,452 over the last 90 days. 2.15% of the stock is owned by insiders.

Huron Consulting Group Trading Down 1.3 %

Shares of HURN stock traded down $1.69 during mid-day trading on Friday, reaching $132.79. 25,171 shares of the stock traded hands, compared to its average volume of 145,417. The company has a market cap of $2.38 billion, a price-to-earnings ratio of 28.86 and a beta of 0.37. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The stock's fifty day simple moving average is $141.81 and its two-hundred day simple moving average is $128.34. Huron Consulting Group Inc. has a 1-year low of $84.26 and a 1-year high of $153.85.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its earnings results on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, topping the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The business had revenue of $399.31 million for the quarter, compared to the consensus estimate of $380.62 million. On average, research analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.